Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results February 9, 2017 Teva CEO Says 2018 Will Be a Year of Falling Sales and Profits February 8, 2018 Say “No” the Right Way: How Declining a Job Offer can Advance Your Career March 1, 2018